GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
These Phase 3 clinical studies are designed to evaluate the safety and efficacy of dotinurad compared to an active control ...
GlobalData on MSN
Arthrosi gains $153m for development of gout therapy
US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is ...
Gout is a type of inflammatory arthritis. It occurs when your blood has a buildup of uric acid. This acid causes crystals to form in a joint, which leads to ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...
Crystalys Therapeutics Inc. ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback